DexCom, Inc. (DXCM)
After hours:
| Previous Close | 71.92 |
| Open | 71.71 |
| Bid | 70.40 x 600 |
| Ask | 70.56 x 3000 |
| Day's Range | 69.71 - 71.87 |
| 52 Week Range | 62.34 - 142.00 |
| Volume | |
| Avg. Volume | 5,450,429 |
| Market Cap | 28.223B |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | 43.75 |
| EPS (TTM) | 1.61 |
| Earnings Date | Oct 24, 2024 - Oct 28, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 97.25 |
Business WireDexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company’s groundbreaking NIL (name, image, likeness) program exclusively for college athletes with diabetes.
Business WireDexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
SAN DIEGO, September 10, 2024--DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by astronauts in space as part of the Polaris Dawn mission, which launched this morning and aims to better understand the effects of spaceflight on human health.
Insider MonkeyHere’s Why DexCom (DXCM) Fell in Q2
Investment advisory firm Ithaka Group released the “Ithaka US Growth Strategy” second-quarter 2024 investor letter. A copy of the letter can be downloaded here. The second quarter of 2024 saw a surge in optimism among global markets, driven by the anticipation of a looser monetary policy from the Federal Reserve and the ongoing development prospects presented by […]
